Billionaire Leon Cooperman Is Buying These 5 Stocks

3. DiaMedica Therapeutics Inc. (NASDAQ:DMAC)

Number of Hedge Fund Holders: 7 

Percentage Increase in Stake During Q4: 50%

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) is a biopharma firm developing treatments for neurological and kidney diseases. Hedge funds have started noticing the stock in recent months. At the end of the third quarter of 2021, 7 hedge funds in the database of Insider Monkey held stakes worth $4.3 million in DiaMedica Therapeutics Inc. (NASDAQ:DMAC), compared to 10 in the preceding quarter worth $8.7 million. 

Latest data shows that Omega Advisors owned 300,000 shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) at the end of December worth $1.1 million, representing 0.05% of the portfolio. The company has featured in the Omega portfolio since the fourth quarter of 2020.